Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Blood sugar self-monitoring in non-insulin treated type 2 diabetes doesn’t improve control

Trial shows no benefits to glycaemic control or health-related quality of life in patients who self-monitor glucose levels.

It has been debated whether self-monitoring blood glucose (SMBG) levels has any value in improving glycaemic control for patients with type 2 diabetes not requiring insulin. Despite this, more than 75% of these patients report doing so regularly.

In a year-long study published in JAMA Internal Medicine[1] (online, 10 June 2017), researchers assigned 450 patients with non-insulin treated diabetes across 15 primary care practices to either once-daily SMBG, once-daily SMBG with tailored feedback via messaging or no SMBG at all.

At the end of the study, the researchers found no significant differences in HbA1c levels, a marker of recent glycaemic control, across the groups. There were also no differences in health-related quality of life.

The researchers say that SMBG should not be routine for patients with non-insulin treated type 2 diabetes and that clinicians should consider it on a case-by-case basis for individual patients.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203053

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Blood glucose monitor

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.